Drug Discovery

Revolutionary approaches to drug discovery aided by informatics and guided toward precision medicine have helped bring new drug approvals back to pre-1996 levels

The Aigenpulse platform harnesses the latest artificial intelligence and machine learning tools to deliver advanced analytics to underpin scientific decision making

Four promising antiviral drug candidates have been identified and analyzed by a University of Arizona-University of South Florida team in a preclinical study

Researchers say their device could mimic any cell type—bacterial, human, or even the tough cell walls of plants

Leading the revolution in CryoEM-enabled drug discovery

Synergistic partnership drives creation of unique range of flexible, scalable services to help accelerate and de-risk drug development

Early approvals for new treatments, such as those for COVID-19, could get delayed by the standards the FDA used for older drugs, according to a new study

Reliable, easy-to-use cryo-EM workflow solution quadruples throughput for pharma labs

A new web resource provides scientists an easy way to see the progress of the structural biology community in studying the protein structures of SARS-CoV-2